Skip to content

Study · Animal study (in vivo) · rat · 2003

1 result

Effect of acute progestational hypoxia on the content of biogenic amines in the brain of albino rat pups: Peptide correction.

Maslova MV, Graf AV, Sokolova NA, Goncharenko EN, Shestakova SV, Kudryashova NY, Andreeva LA

Bulletin of experimental biology and medicine1 Aug 2003

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rat pups, a single intranasal administration of Semax to pregnant females prevented hypoxia-related changes in biogenic amine content in the CNS during postnatal ontogeny.

    In plain wordsIn rats, Semax given once to pregnant mothers prevented changes in brain amine levels in their pups.

    Peptide
    Semax
    Outcome
    Direction not reportedBiogenic amine content in offspring CNS
    Study

    ratn: not reported in source

    Progestational hypobaric hypoxia, offspring of treated pregnant females
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · single administrationAs given in this study (rat).

    Source sentences

    Summary
    Single intranasal administration of Semax heptapeptides and beta-casomorphine-7 to pregnant females prevented changes in the content of biogenic amines in CNS of the offspring during postnatal ontogeny.
    1 context sentence
    Summary · context
    We studied the effect of exposure to acute hypobaric hypoxia in the progestational period on the content of biogenic amines in the brainstem and cerebral cortex in rat pups of different age.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 10:21 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.